Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
This article was originally published in The Tan Sheet
Executive Summary
FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate such formulas as "new drugs," a coalition of public interest groups states in a citizen petition